Revolution Medicines Chief Global Commercialization Officer Anthony Mancini disposes of common shares worth $347,000
Bitget2026/09/22 22:00- Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sold 1,764 common shares on Sep. 18, 2026 at USD 196.94.
- Direct holdings fell to 40,352 shares following the transaction.
- Sale executed under a Rule 10b5-1 trading plan adopted on June 11, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Honda Motor (HMC.US) Reports 65.7% Increase in Net Profit in the First Half, Plans to Expand Production Capacity in North America and Brazil
Honda Motor (HMC.US) released its financial results for the first half of fiscal year 2027 on November 10.
Crypto winter not over? Mining rig hosting provider Bitari cancels orders at the last minute, IPO plans put on hold
Bitcoin mining service provider Bitari has withdrawn its Nasdaq IPO plan. The company originally intended to issue 4.3 million shares at $7 per share to raise $30 million. Its annual revenue is approximately $11 million.
Pre-orders for GTA 6 are booming and may reverse the downward trend! Citigroup raises Take-Two Interactive Software (TTWO.US) target to $270
Citigroup maintains a "Buy" rating on Take-Two Interactive Software, with a target price of $270.
Crypto prices
More
